Sensitivity and specificity of immunological methods for the detection of anti-topoisomerase I (Sc170) autoantibodies: Results of a multicenter study

Clinical Chemistry

Volumn 46, Issue 10, 2000, Pages 1681-1685

  Bizzaro, N ^a   Tonutti, E ^a   Villalta, D ^a   Bassetti, D ^a   Tozzoli, R ^a   Manoni, F ^a   Pirrone, S ^a   Piazza, A ^a   Rizzotti, P ^a   Pradella, M ^a  

^a Ospedale Civile   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; DNA TOPOISOMERASE INHIBITOR;

ANTIBODY DETECTION; ARTICLE; CLINICAL LABORATORY; CLINICAL TRIAL; COUNTER IMMUNOELECTROPHORESIS; DEVICE; DIAGNOSTIC ACCURACY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOBLOTTING; ITALY; MULTICENTER STUDY; SCLERODERMA; SYSTEMIC SCLEROSIS; WESTERN BLOTTING;

EID: 0033775597     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/46.10.1681     Document Type: Article

References (25)

1. High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients
2. Clinical associations of anticentromere antibodies and antibodies to topoisomerase I
3. Scleroderma (systemic sclerosis): Classification, subsets, and pathogenesis
4. Cost-of-illness of scleroderma: The case for rare diseases
5. Autoantibodies to topoisomerase I (Scl70): Analysis by gel diffusion, immunoblot, and enzyme-linked immunosorbent assay
6. The consensus workshop for the detection of autoantibodies to intracellular antigens in rheumatic diseases
7. Autoantibodies to scleroderma-associated antigens
8. Comparison and variation of different methodologies for the detection of autoantibodies to nuclear antigens (ANA)
9. Autoantibody testing for connective tissue diseases. Comparison of immunodiffusion, immunoblot, and enzyme immunoassay
10. Variability between methods to determine ANA, anti-dsDNA and anti-ENA autoantibodies: A collaborative study with the biomedical industry
11. Detectability of autoantibodies to ENA: Comparative investigation of different ELISA reagent set, indirect immunofluorescence and immunoblot
12. Sensitivity of commercial reagents for the detection of anti-ENA antibodies
13. A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificity. I. Precision, sensitivity, and specificity
14. Standards and reference preparations
15. Preliminary criteria for the classification of systemic sclerosis (scleroderma)
16. Autoanticorpi anti-antigeni nucleari estraibili (ENA): Metodi di studio
17. Topoisomerase-I (Scl-70) autoantibodies
18. Autoantibodies in scleroderma
19. Scl-86: A marker antigen for diffuse scleroderma
20. Test performance in systemic sclerosis: Anti-centromere and anti-Scl70 antibodies
21. Specificity of anti-Scl70 antibodies in scleroderma: Increased sensitivity of detection using purified DNA topoisomerase I from calf thymus
22. A recombinant topoisomerase I used for antibody detection in sera from patients with systemic sclerosis
23. A longitudinal study of pulmonary function in Danish patients with systemic sclerosis
24. Survival of patients with systemic and scleroderma specific autoantibodies
25. Linee guida per la diagnosi e il monitoraggio delle malattie reumatiche autoimmuni